Founded Year

2011

Stage

Private Equity | Alive

Total Raised

$2.07M

About AdhereTech

Digital Medical Technologies, dba AdhereTech, creates bottles that measure pills or liquid in real-time, wirelessly send this HIPAA-compliant data into the cloud, and remind patients to take their medication via automated phone call or text message.

AdhereTech Headquarter Location

11 Broadway Suite 457

New York, New York, 10004,

United States

646-417-8143

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

AdhereTech's Products & Differentiation

See AdhereTech's products and how their products differentiate from alternatives and competitors

  • AdhereTech Smart Adherence System

    The AdhereTech Smart Adherence System is proven to improve adherence and extend duration on therapy by empowering patients and healthcare teams to achieve medication success throughout the patient journey: The Smart Bottle gently informs the patient to their dose time and prompts them only if they have not taken their medication. Real-time, 2-way connection with patients via text and phone communications provides a feedback loop that supports patients from day one. Actionable data supports rapid response from live support specialists and alerts to pharmacy care teams ensure patients receive timely support to overcome challenges and stay on therapy.

    Differentiation

    The AdhereTech Smart Adherence System is clinically proven to improve adherence and regulate dose-time variations leading to optimal efficacy and less patient drop-offs. Real-world evidence with pa… 

Expert Collections containing AdhereTech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AdhereTech is included in 8 Expert Collections, including Pharma Supply Chain.

P

Pharma Supply Chain

1,357 items

M

Medical Devices

8,304 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Conference Exhibitors

5,302 items

D

Digital Health

13,070 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

T

Telehealth

2,833 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

H

Health Monitoring & Diagnostics

838 items

Companies offering products that help assess patients’ state of health and well-being from a distance. Tagged as #RemoteMonitoring&Diagnostics

AdhereTech Patents

AdhereTech has filed 5 patents.

The 3 most popular patent topics include:

  • Capacitors
  • Health care
  • Medical terminology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/17/2016

9/11/2018

Computer memory, Capacitors, Remote desktop, Computer data storage, Medical terminology

Grant

Application Date

5/17/2016

Grant Date

9/11/2018

Title

Related Topics

Computer memory, Capacitors, Remote desktop, Computer data storage, Medical terminology

Status

Grant

Latest AdhereTech News

AdhereTech and Massive Bio, Two of NYC Digital Health 100 most Promising Start-Ups, Announce AI-Enabled, Patient-Centric Oncology Solutions Partnership

Jun 8, 2022

Share Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric clinical trial enrollment for oncology, and AdhereTech, a pioneer and leading provider of smart devices that connect patients to care with real-time interventions, announced their partnership to provide advanced, data-driven digital health technology solutions, focusing in oral oncolytic agents providing real-time integrated access to care for cancer patients to precision oncology drugs and leading-edge clinical trials. Both companies were recognized in the 2022 NYC Digital Health 100 which showcases the most exciting digital health companies in the New York region. “We’re excited to partner with a cutting-edge solutions provider in the critical oncology therapeutic category. Collaborating, integrating technology and resources will serve to streamline patient’s journeys and achieve more consistent engagement, enhance care and ultimately improve outcomes and scientific advances” Massive Bio and AdhereTech have committed to combining their products and services to offer global, comprehensive solutions to measure, analyze and monitor precision oncology medication adherence for patients participating in clinical trials and those prescribed commercially available treatments. Both companies currently are contracted with leading pharmaceutical companies and major specialty pharmacies. Their work with payers, pharmacies and pharmaceutical companies to develop adherence programs utilizing device generated data to optimize processes and improve cost-effective measures for specialty drug and clinical trial programs that may save the industry hundreds of billions of dollars per year. “While the conversation around digital health and pharma has expanded well beyond from adherence, in oncology it provides the link between cost-effective treatments, and an opportunity to prioritize clinical trials when most appropriate” mentioned Selin Kurnaz , CEO and Co-Founder of Massive Bio. “Even modest improvements can lead to huge cost savings for payers and the pharmaceutical research industry, while allowing streamlined access in real time to effective on-label precision oncology treatments. It is a win-win situation for all stakeholders, from patients to specialty pharmacies, payers, and the commercial and cancer research ecosystem. AdhereTech is one of the few companies that is successfully achieving those goals, and we are excited about this collaboration”. With over 13,000 active cancer clinical trials in the US at any given time, and dozens of biomarkers and precision oncology molecules under study, Massive Bio aims to use AI and patient-centric concierge services at scale to reach cancer patients globally and accelerate the oncology research and development infrastructure. Massive Bio had recently announced the launch of its NASA-style Oncology Clinical Trial Command Center (OCTCC) to disrupt and accelerate trial enrollment, and also the launch of its 100K Cancer Clinical Trial Singularity Program aimed at matching 100,000 cancer patients in real-time to cutting-edge clinical trials using its Massive Bio’s AI-based technology, website and apps across iOS and Android platforms, expanding their presence as a global company with country-level success in 12 markets. Related Posts AdhereTech is a leader in medication programs, providing commercialized digital solutions to measure and manage medication adherence in a variety of settings, including academics, clinical trials, and commercially prescribed treatments. It develops and produces treatment management solutions utilizing smart devices with integrated cellular technology that, seamlessly, connects patients in real time to confirm when patients take their medication and provides two-way communications to ensure dosing regimens are followed and reports and escalates the reasons for and missed doses. “The Aidia System creates personalized patient support with specialty pharmacies and healthcare teams, enabling timely health interventions when they are necessary, and clinical trials can benefit from those key interventions,” said Chris O’Brien, Chief Executive Officer of AdhereTech. “Upon learning of Massive Bio’s traction in the oncology space, and the opportunities of using our Aidia System, expansive network, and real-world data to help patients, physicians and the cancer research industry at a technology enabled scale, it made absolute sense to explore and operationalize this partnership.” “Our AI-enabled clinical trial and precision oncology therapy-finding technology works at its best when paired up with real-time patient-reported insights” said Arturo Loaiza-Bonilla, M.D., Co-Founder of Massive Bio. “By leveraging real-time data from AdhereTech’s Smart Adherence System in combination with our SYNERGY-AI cancer trial matching platform, we can identify key opportunities for clinical trial enrollment, while also optimizing medication adherence and access in both precision oncology care, and cancer research.” “At AdhereTech, we strive to bring data, analytics and new technologies to market to serve patients and life science companies with better resources in the vital clinical research and treatment realms” said Gregory Gallo, Chief Revenue Officer of AdhereTech. “We’re excited to partner with a cutting-edge solutions provider in the critical oncology therapeutic category. Collaborating, integrating technology and resources will serve to streamline patient’s journeys and achieve more consistent engagement, enhance care and ultimately improve outcomes and scientific advances,” added Gallo.

AdhereTech Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

AdhereTech Rank

  • When was AdhereTech founded?

    AdhereTech was founded in 2011.

  • Where is AdhereTech's headquarters?

    AdhereTech's headquarters is located at 11 Broadway, New York.

  • What is AdhereTech's latest funding round?

    AdhereTech's latest funding round is Private Equity.

  • How much did AdhereTech raise?

    AdhereTech raised a total of $2.07M.

  • Who are the investors of AdhereTech?

    Investors of AdhereTech include Argentum Group and Blueprint Health.

  • Who are AdhereTech's competitors?

    Competitors of AdhereTech include MediSafe and 6 more.

  • What products does AdhereTech offer?

    AdhereTech's products include AdhereTech Smart Adherence System.

You May Also Like

MediSafe Logo
MediSafe

MediSafe helps people integrate healthier behavior into their daily lives with its first-of-its-kind cloud-synced mobile medication management system. Using everyday technologies people already have, the company's technology makes it easier for families and friends to give the support needed to help their loved ones get healthier together.

A
AiCure

AiCure is an AI and advanced data analytics company targeting the health care industry. AiCure uses AI to see, hear and understand how people respond to treatment across clinical trials and patient care. Clinically proven to accurately measure and modify patient behavior, AiCure’s technologies keep patients engaged and optimized to treatment, as well as assess treatment effectiveness.

R
Redi Health

Redi Health develops a platform that empowers patients to take control of and contribute to their health journey.

Perx Health Logo
Perx Health

Perx develops a user-first smartphone app to motivate people to take their medication as prescribed. It does this by providing real rewards and exciting gameplay combined with simple intuitive instructions to make sticking to medication the easy choice every day. The Perx app reminds, educates, and monitors the user's medication regime but most importantly gives them the opportunity to earn rewards every time they stick to their schedule.

A
Ada Health

Ada is a global health company founded by doctors, scientists, and industry pioneers to create new possibilities for personal health. Ada’s core system connects medical knowledge with AI to help people actively manage their health and medical professionals to deliver effective care. Ada collaborates with health systems and global non-profit organizations.

C
CALC Asia

CALC Asia provides users in the insurance industry with an intelligent butler service system - aiFin. Through aiFin platform, users can instantly view and manage data, transaction content, submit and reply to inquiries, set reminders, and commission settlement details.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.